{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T21:50:21Z","timestamp":1793915421453,"version":"4.8.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T00:00:00Z","timestamp":1746144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19125495"],"award-info":[{"award-number":["19125495"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2025,7,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Benzaldehyde (BA) is an aromatic aldehyde found in fruits that has been studied as a potential anticancer agent on the basis of its ability to inhibit transformation in mouse embryo cells and to suppress metastasis in mice.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We investigated the cytotoxic effects of BA on cancer cells, and probed its effects on intracellular signaling pathways. The anticancer effects of BA in vivo were studied by using a mouse orthotopic transplantation model of pancreatic cancer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>BA inhibited the growth of osimertinib- or radiation-resistant cancer cells as well as the interaction between 14-3-3\u03b6 and its client proteins. The interaction of 14-3-3\u03b6 with the Ser<jats:sup>28<\/jats:sup>-phosphorylated form of histone H3 (H3S28ph) was implicated in treatment resistance and the transcriptional regulation of genes related to epithelial-mesenchymal transition and stemness, including <jats:italic>E2F2<\/jats:italic>, <jats:italic>SRSF1<\/jats:italic>, and <jats:italic>ID1<\/jats:italic>. Treatment of mice with a BA derivative inhibited pancreatic tumor growth and lung metastasis, as well as suppressed a state of epithelial-mesenchymal plasticity (EMP) of tumor cells.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The interaction between 14-3-3\u03b6 and H3S28ph plays a key role in EMP and treatment resistance in cancer. The ability of BA to inhibit this and other interactions of 14-3-3\u03b6 offers the potential to overcome treatment resistance and to suppress metastasis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1038\/s41416-025-03006-4","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T14:06:05Z","timestamp":1746194765000},"page":"27-39","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Benzaldehyde suppresses epithelial-mesenchymal plasticity and overcomes treatment resistance in cancer by targeting the interaction of 14-3-3\u03b6 with H3S28ph"],"prefix":"10.1038","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-3748-457X","authenticated-orcid":false,"given":"Jun","family":"Saito","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juntaro","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoyoshi","family":"Koike","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukie","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyomi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Otsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1341-0298","authenticated-orcid":false,"given":"Hiroyuki","family":"Nobusue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oltea","family":"Sampetrean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatsune","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Sugihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6610-1902","authenticated-orcid":false,"given":"Hideyuki","family":"Saya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,2]]},"reference":[{"key":"3006_CR1","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/bjc.1990.313","volume":"62","author":"T Tatsumura","year":"1990","unstructured":"Tatsumura T, Tsujimoto M, Koyama S, Furuno T, Komori Y, Sato H, et al. 4, 6-0-benzylidene-D-glucopyranose (BG) in the treatment of solid malignant tumours, an extended phase I study. Br J Cancer. 1990;62:436\u20139.","journal-title":"Br J Cancer"},{"key":"3006_CR2","first-page":"572","volume":"71","author":"T Nambata","year":"1980","unstructured":"Nambata T, Terada N, Mizutani T, Takeuchi S. Effect of benzaldehyde on mouse embryo cells in vitro. Gan. 1980;71:572\u20133.","journal-title":"Gan"},{"key":"3006_CR3","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/BF00395915","volume":"112","author":"H Ochiai","year":"1986","unstructured":"Ochiai H, Niwayama S, Masuyama K. Inhibition of experimental pulmonary metastasis in mice by beta-cyclodextrin-benzaldehyde. J Cancer Res Clin Oncol. 1986;112:216\u201320.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3006_CR4","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/S0006-291X(79)80010-8","volume":"87","author":"T Miyakawa","year":"1979","unstructured":"Miyakawa T, Zundel JL, Sakaguchi K. Selective inhibitory effect of benzaldehyde on the growth of simian virus 40-transformed cells. Biochem Biophys Res Commun. 1979;87:1024\u201330.","journal-title":"Biochem Biophys Res Commun"},{"key":"3006_CR5","first-page":"2574","volume":"40","author":"M Watanuki","year":"1980","unstructured":"Watanuki M, Sakaguchi K. Selective inhibition by benzaldehyde of the uptake of nucleosides and sugar into simian virus 40-transformed cells. Cancer Res. 1980;40:2574\u20139.","journal-title":"Cancer Res"},{"key":"3006_CR6","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1517\/14728222.2010.531011","volume":"14","author":"CL Neal","year":"2010","unstructured":"Neal CL, Yu D. 14-3-3\u03b6 as a prognostic marker and therapeutic target for cancer. Expert Opin Ther Targets. 2010;14:1343\u201354.","journal-title":"Expert Opin Ther Targets"},{"key":"3006_CR7","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/cgt.2011.85","volume":"19","author":"X Yang","year":"2012","unstructured":"Yang X, Cao W, Zhang L, Zhang W, Zhang X, Lin H. Targeting 14-3-3zeta in cancer therapy. Cancer Gene Ther. 2012;19:153\u20139.","journal-title":"Cancer Gene Ther"},{"key":"3006_CR8","doi-asserted-by":"publisher","first-page":"5587","DOI":"10.1038\/s41388-018-0348-3","volume":"37","author":"KL Pennington","year":"2018","unstructured":"Pennington KL, Chan TY, Torres MP, Andersen JL. The dynamic and stress-adaptive signaling hub of 14-3-3: emerging mechanisms of regulation and context-dependent protein-protein interactions. Oncogene. 2018;37:5587\u2013604.","journal-title":"Oncogene"},{"key":"3006_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.molcel.2005.08.032","volume":"20","author":"N Macdonald","year":"2005","unstructured":"Macdonald N, Welburn JP, Noble ME, Nguyen A, Yaffe MB, Clynes D, et al. Molecular basis for the recognition of phosphorylated and phosphoacetylated histone h3 by 14-3-3. Mol Cell. 2005;20:199\u2013211.","journal-title":"Mol Cell"},{"key":"3006_CR10","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.4161\/cc.7.10.5946","volume":"7","author":"S Winter","year":"2008","unstructured":"Winter S, Fischle W, Seiser C. Modulation of 14-3-3 interaction with phosphorylated histone H3 by combinatorial modification patterns. Cell Cycle. 2008;7:1336\u201342.","journal-title":"Cell Cycle"},{"key":"3006_CR11","doi-asserted-by":"publisher","first-page":"3492","DOI":"10.1038\/sj.onc.1208521","volume":"24","author":"KL Dunn","year":"2005","unstructured":"Dunn KL, Davie JR. Stimulation of the Ras-MAPK pathway leads to independent phosphorylation of histone H3 on serine 10 and 28. Oncogene. 2005;24:3492\u2013502.","journal-title":"Oncogene"},{"key":"3006_CR12","doi-asserted-by":"publisher","first-page":"2193","DOI":"10.1016\/j.biochi.2012.04.018","volume":"94","author":"A Sawicka","year":"2012","unstructured":"Sawicka A, Seiser C. Histone H3 phosphorylation - a versatile chromatin modification for different occasions. Biochimie. 2012;94:2193\u2013201.","journal-title":"Biochimie"},{"key":"3006_CR13","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/mc.20220","volume":"45","author":"Z Dong","year":"2006","unstructured":"Dong Z, Bode AM. The role of histone H3 phosphorylation (Ser10 and Ser28) in cell growth and cell transformation. Mol Carcinog. 2006;45:416\u201321.","journal-title":"Mol Carcinog"},{"key":"3006_CR14","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1158\/0008-5472.CAN-07-6597","volume":"68","author":"HG Kim","year":"2008","unstructured":"Kim HG, Lee KW, Cho YY, Kang NJ, Oh SM, Bode AM, et al. Mitogen- and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformation. Cancer Res. 2008;68:2538\u201347.","journal-title":"Cancer Res"},{"key":"3006_CR15","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/nrc.2017.118","volume":"18","author":"T Brabletz","year":"2018","unstructured":"Brabletz T, Kalluri R, Nieto MA, Weinberg RA. EMT in cancer. Nat Rev Cancer. 2018;18:128\u201334.","journal-title":"Nat Rev Cancer"},{"key":"3006_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41580-020-0237-9","volume":"21","author":"J Yang","year":"2020","unstructured":"Yang J, Antin P, Berx G, Blanpain C, Brabletz T, Bronner M, et al. Guidelines and definitions for research on epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2020;21:341\u201352.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3006_CR17","doi-asserted-by":"publisher","first-page":"25161","DOI":"10.18632\/oncotarget.4629","volume":"6","author":"MK Jolly","year":"2015","unstructured":"Jolly MK, Jia D, Boareto M, Mani SA, Pienta KJ, Ben-Jacob E, et al. Coupling the modules of EMT and stemness: A tunable \u2018stemness window\u2019 model. Oncotarget. 2015;6:25161\u201374.","journal-title":"Oncotarget"},{"key":"3006_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RY, Jackson RA, Thiery JP. EMT: 2016. Cell. 2016;166:21\u201345.","journal-title":"Cell"},{"key":"3006_CR19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s42003-019-0506-3","volume":"2","author":"VY Chung","year":"2019","unstructured":"Chung VY, Tan TZ, Ye J, Huang RL, Lai HC, Kappei D, et al. The role of GRHL2 and epigenetic remodeling in epithelial-mesenchymal plasticity in ovarian cancer cells. Commun Biol. 2019;2:272.","journal-title":"Commun Biol"},{"key":"3006_CR20","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41576-023-00601-0","volume":"24","author":"J Haerinck","year":"2023","unstructured":"Haerinck J, Goossens S, Berx G. The epithelial-mesenchymal plasticity landscape: principles of design and mechanisms of regulation. Nat Rev Genet. 2023;24:590\u2013609.","journal-title":"Nat Rev Genet"},{"key":"3006_CR21","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ccr.2005.08.008","volume":"8","author":"N Hay","year":"2005","unstructured":"Hay N. The Akt-mTOR tango and its relevance to cancer. Cancer Cell. 2005;8:179\u201383.","journal-title":"Cancer Cell"},{"key":"3006_CR22","doi-asserted-by":"publisher","first-page":"12487","DOI":"10.1074\/jbc.M114.607580","volume":"290","author":"JB Mortenson","year":"2015","unstructured":"Mortenson JB, Heppler LN, Banks CJ, Weerasekara VK, Whited MD, Piccolo SR, et al. Histone deacetylase 6 (HDAC6) promotes the pro-survival activity of 14-3-3\u03b6 via deacetylation of lysines within the 14-3-3\u03b6 binding pocket. J Biol Chem. 2015;290:12487\u201396.","journal-title":"J Biol Chem"},{"key":"3006_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09734-5","volume":"10","author":"J Bertran-Alamillo","year":"2019","unstructured":"Bertran-Alamillo J, Cattan V, Schoumacher M, Codony-Servat J, Gim\u00e9nez-Capit\u00e1n A, Cantero F, et al. AURKB as a target in non-small cell lung cancer with acquired resistance to anti-EGFR therapy. Nat Commun. 2019;10:1812.","journal-title":"Nat Commun"},{"key":"3006_CR24","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1093\/nar\/gku1350","volume":"43","author":"N Kunowska","year":"2015","unstructured":"Kunowska N, Rotival M, Yu L, Choudhary J, Dillon N. Identification of protein complexes that bind to histone H3 combinatorial modifications using super-SILAC and weighted correlation network analysis. Nucleic Acids Res. 2015;43:1418\u201332.","journal-title":"Nucleic Acids Res"},{"key":"3006_CR25","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1002\/hep.27492","volume":"61","author":"P Reichl","year":"2015","unstructured":"Reichl P, Dengler M, van Zijl F, Huber H, F\u00fchrlinger G, Reichel C, et al. Axl activates autocrine transforming growth factor-\u03b2 signaling in hepatocellular carcinoma. Hepatology. 2015;61:930\u201341.","journal-title":"Hepatology"},{"key":"3006_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08074-0","volume":"10","author":"H Taniguchi","year":"2019","unstructured":"Taniguchi H, Yamada T, Wang R, Tanimura K, Adachi Y, Nishiyama A, et al. AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells. Nat Commun. 2019;10:259.","journal-title":"Nat Commun"},{"key":"3006_CR27","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.semcancer.2006.03.004","volume":"16","author":"G Tzivion","year":"2006","unstructured":"Tzivion G, Gupta VS, Kaplun L, Balan V. 14-3-3 proteins as potential oncogenes. Semin Cancer Biol. 2006;16:203\u201313.","journal-title":"Semin Cancer Biol"},{"key":"3006_CR28","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41568-019-0143-7","volume":"19","author":"LN Kent","year":"2019","unstructured":"Kent LN, Leone G. The broken cycle: E2F dysfunction in cancer. Nat Rev Cancer. 2019;19:326\u201338.","journal-title":"Nat Rev Cancer"},{"key":"3006_CR29","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.molcel.2009.08.020","volume":"35","author":"A Lal","year":"2009","unstructured":"Lal A, Navarro F, Maher CA, Maliszewski LE, Yan N, O\u2019Day E, et al. miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to \u201cseedless\u201d 3\u2019UTR microRNA recognition elements. Mol Cell. 2009;35:610\u201325.","journal-title":"Mol Cell"},{"key":"3006_CR30","doi-asserted-by":"publisher","first-page":"3831","DOI":"10.1016\/j.febslet.2012.08.023","volume":"586","author":"N Wu","year":"2012","unstructured":"Wu N, Xiao L, Zhao X, Zhao J, Wang J, Wang F, et al. miR-125b regulates the proliferation of glioblastoma stem cells by targeting E2F2. FEBS Lett. 2012;586:3831\u20139.","journal-title":"FEBS Lett"},{"key":"3006_CR31","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s13105-016-0512-6","volume":"72","author":"H Song","year":"2016","unstructured":"Song H, Zhang Y, Liu N, Zhang D, Wan C, Zhao S, et al. Let-7b inhibits the malignant behavior of glioma cells and glioma stem-like cells via downregulation of E2F2. J Physiol Biochem. 2016;72:733\u201344.","journal-title":"J Physiol Biochem"},{"key":"3006_CR32","doi-asserted-by":"publisher","first-page":"E8247","DOI":"10.1073\/pnas.1610921114","volume":"113","author":"AD Gujar","year":"2016","unstructured":"Gujar AD, Le S, Mao DD, Dadey DY, Turski A, Sasaki Y, et al. An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma. Proc Natl Acad Sci USA. 2016;113:E8247\u2013e56.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3006_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.153030","volume":"216","author":"H Yu","year":"2020","unstructured":"Yu H, Zhang D, Li Z, Wang M. E2F transcription factor 8 promotes proliferation and radioresistance in glioblastoma. Pathol Res Pract. 2020;216:153030.","journal-title":"Pathol Res Pract"},{"key":"3006_CR34","doi-asserted-by":"publisher","first-page":"320","DOI":"10.7150\/ijbs.37686","volume":"16","author":"LK Kim","year":"2020","unstructured":"Kim LK, Park SA, Eoh KJ, Heo TH, Kim YT, Kim HJ. E2F8 regulates the proliferation and invasion through epithelial-mesenchymal transition in cervical cancer. Int J Biol Sci. 2020;16:320\u20139.","journal-title":"Int J Biol Sci"},{"key":"3006_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/nrc3638","volume":"14","author":"A Lasorella","year":"2014","unstructured":"Lasorella A, Benezra R, Iavarone A. The ID proteins: master regulators of cancer stem cells and tumour aggressiveness. Nat Rev Cancer. 2014;14:77\u201391.","journal-title":"Nat Rev Cancer"},{"key":"3006_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30489-z","volume":"13","author":"AE Hall","year":"2022","unstructured":"Hall AE, Pohl S, Cammareri P, Aitken S, Younger NT, Raponi M, et al. RNA splicing is a key mediator of tumour cell plasticity and a therapeutic vulnerability in colorectal cancer. Nat Commun. 2022;13:2791.","journal-title":"Nat Commun"},{"key":"3006_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3389\/fgene.2017.00031","volume":"8","author":"J Balzeau","year":"2017","unstructured":"Balzeau J, Menezes MR, Cao S, Hagan JP. The LIN28\/let-7 Pathway in Cancer. Front Genet. 2017;8:31.","journal-title":"Front Genet"},{"key":"3006_CR38","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1101\/gr.176255.114","volume":"24","author":"A Sawicka","year":"2014","unstructured":"Sawicka A, Hartl D, Goiser M, Pusch O, Stocsits RR, Tamir IM, et al. H3S28 phosphorylation is a hallmark of the transcriptional response to cellular stress. Genome Res. 2014;24:1808\u201320.","journal-title":"Genome Res"},{"key":"3006_CR39","doi-asserted-by":"crossref","unstructured":"Forte E, Chimenti I, Rosa P, Angelini F, Pagano F, Calogero A, et al. EMT\/MET at the Crossroad of Stemness, Regeneration and Oncogenesis: The Ying-Yang Equilibrium Recapitulated in Cell Spheroids. Cancers (Basel). 2017;9:98.","DOI":"10.3390\/cancers9080098"},{"key":"3006_CR40","doi-asserted-by":"crossref","unstructured":"Erstad DJ, Sojoodi M, Taylor MS, Ghoshal S, Razavi AA, Graham-O\u2019Regan KA, et al. Orthotopic and heterotopic murine models of pancreatic cancer and their different responses to FOLFIRINOX chemotherapy. Dis Model Mech. 2018;11:dmm034793.","DOI":"10.1242\/dmm.034793"},{"key":"3006_CR41","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","volume":"7","author":"SR Hingorani","year":"2005","unstructured":"Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB, Hruban RH, et al. Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell. 2005;7:469\u201383.","journal-title":"Cancer Cell"},{"key":"3006_CR42","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.devcel.2018.05.027","volume":"45","author":"NM Aiello","year":"2018","unstructured":"Aiello NM, Maddipati R, Norgard RJ, Balli D, Li J, Yuan S, et al. EMT Subtype Influences Epithelial Plasticity and Mode of Cell Migration. Dev Cell. 2018;45:681\u201395.e4.","journal-title":"Dev Cell"},{"key":"3006_CR43","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.ccr.2012.04.036","volume":"21","author":"CA O\u2019Brien","year":"2012","unstructured":"O\u2019Brien CA, Kreso A, Ryan P, Hermans KG, Gibson L, Wang Y, et al. ID1 and ID3 regulate the self-renewal capacity of human colon cancer-initiating cells through p21. Cancer Cell. 2012;21:777\u201392.","journal-title":"Cancer Cell"},{"key":"3006_CR44","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.stem.2014.01.009","volume":"14","author":"M Todaro","year":"2014","unstructured":"Todaro M, Gaggianesi M, Catalano V, Benfante A, Iovino F, Biffoni M, et al. CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. Cell Stem Cell. 2014;14:342\u201356.","journal-title":"Cell Stem Cell"},{"key":"3006_CR45","doi-asserted-by":"publisher","first-page":"7205","DOI":"10.1021\/bi027343p","volume":"42","author":"D Alvarez","year":"2003","unstructured":"Alvarez D, Callejo M, Shoucri R, Boyer L, Price GB, Zannis-Hadjopoulos M. Analysis of the cruciform binding activity of recombinant 14-3-3zeta-MBP fusion protein, its heterodimerization profile with endogenous 14-3-3 isoforms, and effect on mammalian DNA replication in vitro. Biochemistry. 2003;42:7205\u201315.","journal-title":"Biochemistry"},{"key":"3006_CR46","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.tibs.2007.09.012","volume":"33","author":"M Zannis-Hadjopoulos","year":"2008","unstructured":"Zannis-Hadjopoulos M, Yahyaoui W, Callejo M. 14-3-3 cruciform-binding proteins as regulators of eukaryotic DNA replication. Trends Biochem Sci. 2008;33:44\u201350.","journal-title":"Trends Biochem Sci"},{"key":"3006_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2199-12-33","volume":"12","author":"V Br\u00e1zda","year":"2011","unstructured":"Br\u00e1zda V, Laister RC, Jagelsk\u00e1 EB, Arrowsmith C. Cruciform structures are a common DNA feature important for regulating biological processes. BMC Mol Biol. 2011;12:33.","journal-title":"BMC Mol Biol"},{"key":"3006_CR48","doi-asserted-by":"publisher","first-page":"33213","DOI":"10.1074\/jbc.M103973200","volume":"276","author":"S Zhong","year":"2001","unstructured":"Zhong S, Jansen C, She QB, Goto H, Inagaki M, Bode AM, et al. Ultraviolet B-induced phosphorylation of histone H3 at serine 28 is mediated by MSK1. J Biol Chem. 2001;276:33213\u20139.","journal-title":"J Biol Chem"},{"key":"3006_CR49","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.molcel.2016.09.026","volume":"64","author":"SZ Josefowicz","year":"2016","unstructured":"Josefowicz SZ, Shimada M, Armache A, Li CH, Miller RM, Lin S, et al. Chromatin Kinases Act on Transcription Factors and Histone Tails in Regulation of Inducible Transcription. Mol Cell. 2016;64:347\u201361.","journal-title":"Mol Cell"},{"key":"3006_CR50","doi-asserted-by":"publisher","first-page":"6640","DOI":"10.1093\/nar\/gkm737","volume":"35","author":"JM Sun","year":"2007","unstructured":"Sun JM, Chen HY, Espino PS, Davie JR. Phosphorylated serine 28 of histone H3 is associated with destabilized nucleosomes in transcribed chromatin. Nucleic Acids Res. 2007;35:6640\u20137.","journal-title":"Nucleic Acids Res"},{"key":"3006_CR51","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.molcel.2010.08.020","volume":"39","author":"SS Gehani","year":"2010","unstructured":"Gehani SS, Agrawal-Singh S, Dietrich N, Christophersen NS, Helin K, Hansen K. Polycomb group protein displacement and gene activation through MSK-dependent H3K27me3S28 phosphorylation. Mol Cell. 2010;39:886\u2013900.","journal-title":"Mol Cell"},{"key":"3006_CR52","doi-asserted-by":"publisher","first-page":"2801","DOI":"10.1073\/pnas.1012798108","volume":"108","author":"PN Lau","year":"2011","unstructured":"Lau PN, Cheung P. Histone code pathway involving H3 S28 phosphorylation and K27 acetylation activates transcription and antagonizes polycomb silencing. Proc Natl Acad Sci USA. 2011;108:2801\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3006_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21188-2","volume":"12","author":"J Li","year":"2021","unstructured":"Li J, Mahata B, Escobar M, Goell J, Wang K, Khemka P, et al. Programmable human histone phosphorylation and gene activation using a CRISPR\/Cas9-based chromatin kinase. Nat Commun. 2021;12:896.","journal-title":"Nat Commun"},{"key":"3006_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.542007","volume":"10","author":"J Cui","year":"2020","unstructured":"Cui J, Song Y, Han X, Hu J, Chen Y, Chen X, et al. Targeting 14-3-3\u03b6 Overcomes Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Lung Adenocarcinoma via BMP2\/Smad\/ID1 Signaling. Front Oncol. 2020;10:542007.","journal-title":"Front Oncol"},{"key":"3006_CR55","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/s41586-018-0040-3","volume":"556","author":"I Pastushenko","year":"2018","unstructured":"Pastushenko I, Brisebarre A, Sifrim A, Fioramonti M, Revenco T, Boumahdi S, et al. Identification of the tumour transition states occurring during EMT. Nature. 2018;556:463\u20138.","journal-title":"Nature"},{"key":"3006_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen EY, Tan CM, Kou Y, Duan Q, Wang Z, Meirelles GV, et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics. 2013;14:128.","journal-title":"BMC Bioinformatics"},{"key":"3006_CR57","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD, Fernandez NF, Duan Q, Wang Z, et al. Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res. 2016;44:W90\u20137.","journal-title":"Nucleic Acids Res"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03006-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03006-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03006-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T14:30:37Z","timestamp":1757169037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03006-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,2]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7,27]]}},"alternative-id":["3006"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03006-4","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,2]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study did not require ethics approval or consent to participate because no human subjects, human-derived materials, or patient data were used. All experiments were conducted using established cell lines and animal models. Ethics approval for the animal studies was obtained from the Keio University Animal Care Committee (approval no. 19036) as well as the Recombinant DNA Experiment Committee (protocol no. D2019-013, registration no. D000239), and all procedures were performed in accordance with established guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}